FDA lifts partial clinical hold on Rezolute hypoglycemia treatment
Resolute said the U.S. Food and Drug Administration has lifted the partial clinical hold on its late-stage study testing its treatment for low blood sugar, sending its shares up 11% to $4.83.
ENTRADAS POPULARES
Bluetongue outbreak in a Portuguese sheep farm has broken out
septiembre 19, 2024
Austria says disaster fund to rise to 1 billion euros
septiembre 19, 2024
Portugal gets help from Spain and Morocco in response to fires
septiembre 19, 2024
Drought reduces Amazon rivers to historic lows
septiembre 19, 2024
TRANSMISIÓN EN VIVO